South Dakota biologics regulations.

Who may administer PRP, exosomes and stem cells in South Dakota, and which agencies to check.

A physician at a desk reading regulatory documents

Who may administer biologics in South Dakota?

In South Dakota, stem cell therapy and related biologic treatments must be performed by licensed healthcare providers (MDs/DOs).

Official sources

South Dakota compliance guide.

FDA Compliance

The FDA regulates human cells, tissues, and cellular and tissue-based products (HCT/Ps) under 21 CFR Part 1271. Clinics must ensure that their procedures align with these federal standards to be compliant. Key areas include the registration of the clinic, adhering to proper labeling, and maintaining transparent practices that reflect FDA guidelines.

State Regulations

South Dakota adheres to specific regulations that govern the use and administration of biologics. For the most accurate and up-to-date information, visit the South Dakota Department of Health. State laws may be more flexible than federal standards in certain aspects, but clinics must ensure full understanding and compliance with both.

Provider Qualifications

In South Dakota, stem cell therapy and related biologic treatments must be performed by licensed healthcare providers (MDs/DOs). Providers can check their credentialing requirements through the South Dakota Board of Medical and Osteopathic Examiners.

Patient Informed Consent

Obtaining informed consent is crucial. Consent forms must detail the potential risks, benefits, and the experimental status of certain therapies. This ensures patients understand what they are agreeing to and helps protect the clinic from liability.

Additional Compliance Areas

Pre-Treatment and Post-Treatment Protocols

Clinics should implement clear protocols for patient care before and after treatment. These protocols help maintain consistency in quality and patient safety.

Standard Operating Procedures (SOPs)

Detailed SOPs are necessary for maintaining consistent practices in the administration of biologic treatments. Regular review and updates of these documents are recommended.

Medical Liability Insurance

Ensure that your clinic has adequate medical liability insurance that covers biologic procedures to protect against potential claims.

Marketing Compliance

Marketing materials should accurately reflect the services offered and avoid unsubstantiated claims. Consult the Federal Trade Commission (FTC) for guidelines on compliant marketing practices.

This guide is a general summary to help clinics understand compliance requirements for biologics in South Dakota. It is not legal advice. Regulations change; consult legal counsel and the agencies above before acting on it.

South Dakota: common questions.

Who can administer stem cells, PRP and exosomes in South Dakota?
In South Dakota, stem cell therapy and related biologic treatments must be performed by licensed healthcare providers (MDs/DOs). This is a general summary, not legal advice. Confirm with the state board.
Are stem cell and exosome therapies FDA-approved in South Dakota?
FDA rules are federal, so they apply in South Dakota as everywhere else. Exosome and stem cell therapies are not FDA-approved for therapeutic use, and PRP applications are considered off-label.
Do I need an IRB-approved study to offer biologics in South Dakota?
Investigational treatment belongs inside a reviewed study with proper informed consent. IRB review is not FDA authorisation: culture-expanded and other more-than-minimally-manipulated cell products generally need an IND before use in people.
How do I start offering biologics in South Dakota?
Start with the live webinar, then a discovery call and live training. After that we verify your South Dakota licence, protocol, product sourcing, consent process and advertising before you are listed for patient inquiries.

Practising in South Dakota? Start with the webinar.

Live on Zoom, Tuesdays at 12:00 PM ET. See how the model works before you commit to anything.